Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RFPL1 antisense RNA 1 (RFPL1S) is a human long non-coding RNA (lncRNA) classified as an antisense transcript located on chromosome 22. It is a non-protein-coding RNA with two exons and does not have protein-coding potential. The gene may be involved in gene regulation mechanisms common to antisense lncRNAs, such as modulating adjacent or overlapping protein-coding gene expression. Direct biological functions, molecular partners, or disease mechanisms specific to RFPL1S are not established in current public resources. No evidence supports RFPL1S as a receptor, enzyme, or other traditional drug target, nor is there evidence for direct drug interactions or biomarker status[5][1][2][4].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RFPL1 antisense RNA 1 (RFPL1S).